Special Report: Developer of a new class of synthetic anti-infectives, Recce Pharmaceuticals is boosting its balance sheet securing a debt facility of up to ~$30 million to support Phase III ...

strengthening cash position to ~$27.5m Special Report: Developer of a new class of synthetic anti-infectives, Recce Pharmaceuticals is boosting its balance sheet securing a debt facility of up to ...

A new member has joined director Puri Jagannadh and starring Tamil powerhouse Vijay Sethupathi in their upcoming pan-India ...

Akshay Kumar starrer Welcome To The Jungle lately has been grabbing headlines ever since the film went on floors in 2023. The film which was scheduled to release last year, has been facing several ...

Akshay Kumar’s Welcome 3 faces major delays due to financial issues and cancelled schedules, leaving cast uncertain. Some ...

Akshay Kumar-led multistarrer, Welcome To The Jungle, has reportedly hit a roadblock in production. As per media reports, the film is facing long delays due to financial troubles.

The ASX fell 0.04pc on weakness in utilities. Uranium stocks climbed after Sprott signalled it would buy US$200m in physical ...

Check your free credit score and credit report as often as you want, and get alerts about changes so you can manage your credit effectively. Credit education Stay on top of your score with ...

An analyst recently listed every team's worst trade of the last 10 years, and the choice for the Los Angeles Chargers wasn't at all surprising. The Dallas Cowboys bring in one of the top defensive ...

Now, it has reinforced those claims with a second, highly critical report. The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer ...